EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62020TJ0637
Judgment of the General Court (Third Chamber) of 6 October 2021.
Dermavita Company SARL v European Union Intellectual Property Office.
EU trade mark – Invalidity proceedings – EU word mark JUVÉDERM VOLITE – Late payment of the appeal fee – Inadmissibility of the appeal before the Board of Appeal – Article 101(4) of Regulation (EU) 2017/1001 – Article 106(1)(b) of Regulation 2017/1001 – Restitutio in integrum.
Case T-637/20.
Judgment of the General Court (Third Chamber) of 6 October 2021.
Dermavita Company SARL v European Union Intellectual Property Office.
EU trade mark – Invalidity proceedings – EU word mark JUVÉDERM VOLITE – Late payment of the appeal fee – Inadmissibility of the appeal before the Board of Appeal – Article 101(4) of Regulation (EU) 2017/1001 – Article 106(1)(b) of Regulation 2017/1001 – Restitutio in integrum.
Case T-637/20.
ECLI identifier: ECLI:EU:T:2021:658
Judgment of the General Court (Third Chamber) of 6 October 2021 –
Dermavita Company v EUIPO – Allergan Holdings France (JUVÉDERM VOLITE)
(Case T‑637/20)
(EU trade mark – Invalidity proceedings – EU word mark JUVÉDERM VOLITE – Late payment of the appeal fee – Inadmissibility of the appeal before the Board of Appeal – Article 101(4) of Regulation (EU) 2017/1001 – Article 106(1)(b) of Regulation 2017/1001 – Restitutio in integrum)
|
1. |
EU trade mark – Procedural provisions – Restitutio in integrum – Applicability to the prescribed time limit for paying appeal fees (European Parliament and Council Regulation 2017/1001, Arts 68, 104(5) and 105(1) and (2)) (see para. 35) |
|
2. |
EU trade mark – Decisions of the Office – No obligation to inform the parties of the legal remedies available and of the time limits (European Parliament and Council Regulation 2017/1001, Arts 68 and 104; Commission Regulation No 2018/625, Art. 68) (see para. 36) |
Re:
Action brought against the decision of the Fourth Board of Appeal of EUIPO of 21 August 2020 (Case R 1015/2020-4), relating to invalidity proceedings between Dermavita Company and Allergan Holdings France.
Operative part
The Court:
|
1. |
Dismisses the action; |
|
2. |
Orders Dermavita Company S.a.r.l. to pay the costs. |